Respiratory Medication Adherence in Chronic Lung Disease of Prematurity

被引:14
|
作者
Collaco, J. Michael [1 ]
Kole, Amanda J. [1 ]
Riekert, Kristin A. [1 ]
Eakin, Michelle N. [1 ]
Okelo, Sande O. [1 ]
McGrath-Morrow, Sharon A. [1 ]
机构
[1] Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21287 USA
关键词
bronchopulmonary dysplasia; chronic lung disease; preterm; prematurity; adherence; compliance; health beliefs; INNER-CITY CHILDREN; BRONCHOPULMONARY DYSPLASIA; CYSTIC-FIBROSIS; ASTHMA; MORBIDITY; BARRIERS; BELIEFS; THERAPY; INFANTS; IMPACT;
D O I
10.1002/ppul.21547
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Chronic lung disease of prematurity (CLDP) is a frequent complication of premature birth. Infants and children with CLDP are often prescribed complex medication regimens, which can be difficult for families to manage. Objective: We sought to determine whether non-adherence was associated with increased CLDP-related morbidities and to identify predictors of adherence. Methods: Recruited caregivers of 194 children with CLDP completed questionnaires regarding self-reported adherence, respiratory outcomes, and quality of life (January 2008-June 2010). Adherence data were available for 176 subjects, of whom 143 had self-reported data only, and 33 had prescription claims data, which were used to calculate a medication possession ratio (MPR). Participants in the Prescription Claims Sample (n = 33) were more likely to have public insurance ( P < 0.001). Results: Self-reported adherence substantially overestimated medication possession; the mean MPR was 38.8% (n = 33) and was not associated with self-reported adherence (P = 0.71; n = 26). In a small sample, higher MPR was associated with decreased odds ratios of visiting the emergency department (ED) (OR = 0.75 for a 10% increase in MPR [95% CI: 0.58, 0.97]; P 0.03; n = 74 questionnaires from 28 participants), activity limitations (OR = 0.71 [95% CI: 0.53, 0.95]; P = 0.02; n = 70 questionnaires from 28 participants), and rescue medication use (OR = 0.84 [95% CI: 0.73-0.98]; P = 0.03; n = 70 questionnaires from 28 participants). Increasing caregiver worries regarding medication efficacy and side effects were associated with lower MPR (P = 0.04 and 0.02, respectively; n = 62 questionnaires from 27 participants). Socio-demographic and clinical risk factors were not predictors of MPR (n = 33). Conclusions: We found that non-adherence with respiratory medications was common in premature infants and children with CLDP. Using multiple timepoints in a small sample, non-adherence was associated with a higher likelihood of respiratory morbidities. Although self-reported adherence and demographic characteristics did not predict MPR, concerns about medications did. We suggest that addressing caregiver concerns about medications may improve adherence and ultimately decrease CLDP-related morbidities. Larger, prospective studies are needed to confirm these findings and determine which factors predict non-adherence. Pediatr Pulmonol. 2012; 47:283-291. (C) Wiley Periodicals, Inc.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [1] Medication Adherence in Chronic Lung Disease of Prematurity
    Collaco, J. M.
    Kole, A.
    Okelo, S.
    Riekert, K. A.
    Eakin, M.
    McGrath-Morrow, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [2] Chronic Lung Disease of Prematurity: Long-Term Respiratory Outcome
    El Mazloum, Dania
    Moschino, Laura
    Bozzetto, Sara
    Baraldi, Eugenio
    NEONATOLOGY, 2014, 105 (04) : 352 - 356
  • [3] Chronic lung disease of prematurity and respiratory outcome at eight years of age
    Kulasekaran, Karthikeyan
    Gray, Peter H.
    Masters, Brent
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (1-2) : 44 - 48
  • [4] CHRONIC LUNG DISEASE OF PREMATURITY: LONG-TERM RESPIRATORY OUTCOME
    Baraldi, E.
    CHILD CARE HEALTH AND DEVELOPMENT, 2010, 36 : 6 - 7
  • [5] Adherence to respiratory medications in VA patients with chronic lung disease
    Lee, TA
    Bartle, B
    McLaughlin, T
    Dirani, R
    VALUE IN HEALTH, 2005, 8 (03) : 327 - 328
  • [6] ADHERENCE TO GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS IMMUNOPROPHYLAXIS AMONG INFANTS WITH PREMATURITY OR CHRONIC LUNG DISEASE IN THREE UNITED STATES COUNTIES
    Carroll, Kecia N.
    Griffin, Marie R.
    Edwards, Kathryn M.
    Ali, Asad
    Zhu, Yuwei
    Iwane, Marika K.
    Szilagyi, Peter G.
    Staat, Mary A.
    Stevens, Timothy P.
    Hall, Caroline B.
    Williams, John V.
    Hartert, Tina V.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (11) : E229 - E231
  • [7] Day Care Increases the Risk of Respiratory Morbidity in Chronic Lung Disease of Prematurity
    McGrath-Morrow, Sharon A.
    Lee, Grace
    Stewart, Beth H.
    McGinley, Brian M.
    Lefton-Greif, Maureen A.
    Okelo, Sande O.
    Collaco, J. Michael
    PEDIATRICS, 2010, 126 (04) : 632 - 637
  • [8] Adherence to medication: The challenge of chronic disease
    Grimaldi, A.
    REVUE DE MEDECINE INTERNE, 2009, 30 (01): : 1 - 2
  • [9] ASSESSING CHRONIC DISEASE MEDICATION ADHERENCE
    Nobles, B. M.
    Erickson, S.
    Marshall, V
    VALUE IN HEALTH, 2018, 21 : S226 - S226
  • [10] CHRONIC LUNG-DISEASE OF PREMATURITY
    SCHICK, JB
    GOETZMAN, BW
    PEDIATRICS, 1985, 76 (04) : 652 - 652